Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20μg and Drospirenone 3mg

被引：0
|
作者：
D. Cibula
U. Karck
H. G. Weidenhammer
J. Kunz
S. Alincic
J. Marr
机构：
[1] Charles University,Department of Obstetrics and Gynaecology, General Faculty Hospital
[2] University of Freiburg,Department of Obstetrics and Gynaecology
[3] Klarastr,undefined
[4] Hospital Zollikerberg,undefined
[5] Schering AG,undefined
[6] MDG G&A,undefined
来源：
Clinical Drug Investigation | 2006年 / 26卷
关键词：
Combine Oral Contraceptive; Contraceptive Efficacy; Drospirenone; Withdrawal Bleeding; Normal Menstruation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The purpose of this study was to assess the efficacy and safety of a new low-dose oral contraceptive containing ethinylestradiol 20μg and drospirenone 3mg (EE 20μg/drsp 3mg).
引用
收藏
页码：143 / 150
页数：7
相关论文
共 38 条
  • [1] Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone
    Bachmann, G
    Sulak, PJ
    Sampson-Landers, C
    Benda, N
    Marr, J
    CONTRACEPTION, 2004, 70 (03) : 191 - 198
  • [2] Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
    Laszlo Hernadi
    Marr, Joachim
    Trummer, Dietmar
    De Leo, Vincenzo
    Petraglia, Felice
    CONTRACEPTION, 2009, 80 (01) : 18 - 24
  • [3] Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women
    Anzai, Yuzuru
    Heger-Mahn, Doris
    Schellschmidt, Ilka
    Marr, Joachim
    CONTRACEPTION, 2012, 86 (01) : 28 - 34
  • [4] The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 μg and ethinylestradiol 15 μg
    Bocci, A.
    Spielniann, D.
    Azzini, Pr
    Guaschino, Pr
    Affronti, G.
    Villani, Pr
    Boselli, Pr
    Genazzani, Pr
    Flamigni, Z. C.
    Omodei, U.
    Bolis, P.
    Marsoni, V.
    Luerti, M.
    Simenel, J. L.
    Ouvry-Neveu, B.
    Andre, G.
    David, S.
    Durand, J. L.
    Ehret-Mentre, C.
    Gensburger, J. M.
    Goetzmann, P.
    Jung-Faerber, S.
    Keller, D.
    Lempereur, M.
    Plumere, C.
    Spielmann, A.
    Katz, J. L.
    Sebaoun, J.
    Belaisch, J.
    Hammer, F.
    Salama, B.
    Aissaoui, S.
    Taube, A. M.
    Nakache, H.
    Soria, J.
    Joffo, M.
    Lardenois, H.
    Leclerc, P.
    Ponsar, C.
    Saubry-Bobet, V.
    Blaiset, E.
    Veyres, F.
    Clamp, M.
    Menon, K. V. K.
    Moran, D. G.
    Randall, S.
    Shaw, P. J.
    Bruni, V.
    Massobrio, M.
    Crosignani, P.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 1999, 4 : 9 - 15
  • [5] Yasminelle (R) : a new low-dose combined oral contraceptive containing drospirenone
    Sillem, Martin
    WOMENS HEALTH, 2006, 2 (04) : 551 - 559
  • [6] A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen
    Marr, Joachim
    Gerlinger, Christoph
    Kunz, Michael
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 162 (01) : 91 - 95
  • [7] Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma
    Taniguchi, Fuminori
    Enatsu, Akiko
    Ota, Ikuko
    Toda, Toshiko
    Arata, Kazuya
    Harada, Tasuku
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2015, 191 : 116 - 120
  • [8] Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: physical and emotional benefits
    Heskamp, Marie-Luise S.
    Schramm, Georg A. K.
    CONTRACEPTION, 2010, 81 (01) : 49 - 56
  • [9] Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women
    Galvao Giribela, Cassiana Rosa
    Consolim-Colombo, Fernanda Marciano
    Nisenbaum, Marcelo Gil
    de Moraes, Tercio Lemos
    Galvao Giribela, Aricia Helena
    Baracat, Edmund Chada
    de Melo, Nilson Roberto
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (11) : 912 - 915
  • [10] Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis
    Koltun, William
    Maloney, J. Michael
    Marr, Joachim
    Kunz, Michael
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 155 (02) : 171 - 175
1234